RET Inhibitors in Medullary Thyroid Cancer

About this episode

Drs Kaniksha Desai and Mimi Hu discuss the use of RET inhibitors in treating advanced medullary thyroid cancer.

Drs Kaniksha Desai and Mimi Hu discuss RET inhibitors for advanced medullary thyroid cancer on the Thyroid Stimulating Podcast. This podcast is intended for healthcare professionals only . To read a partial transcript or to comment, visit: https://www.medscape.com/index/list_15483_0 Kaniksha Desai, MD, Associate Professor of Medicine, Department of Endocrinology, Stanford School of Medicine, Palo Alto, California Mimi I. Hu, MD, Professor, Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, Texas

People in this episode

Guests: Kaniksha Desai, Mimi Hu

Topics covered

• RET inhibitors
• medullary thyroid cancer
• oncology
• endocrinology
• advanced cancer treatment

Keywords

• RET inhibitors
• medullary thyroid cancer
• cancer treatment
• endocrinology
• oncology
• advanced cancer

Mentioned in this episode

Organizations: Stanford School of Medicine, The University of Texas MD Anderson Cancer Center

More episodes of The Thyroid Stimulating Podcast

• Secondary Hypothyroidism: Why TSH Is Misleading · June 10, 2026 · 21 min
• A Lifespan Approach to Thyroid Biology · April 15, 2026 · 36 min
• Medications and the Thyroid: Mechanisms and Management · March 25, 2026 · 37 min
• Adding to the Toolbox: Thyroid Artery Embolization · February 24, 2026 · 59 min
• Nanosecond Pulsed Field Ablation: Expanding the Toolbox · January 12, 2026 · 42 min
• Active Surveillance for Low-Risk Papillary Thyroid Cancer · December 10, 2025 · 29 min